Current assets: Cash and marketable securities Accounts receivable. Inventory Total Assets Fixed assets: Gross plant and equipment Less: Accumulated depreciation Net plant and equipment Other long-term assets Total Total assets Net sales Less: Cost of goods sold Gross profits Less: Other operating expenses Less: Common stock dividends Addition to retained earnings Per (common) share data: Earnings per share (EPS) Dividends per share (DPS) Book value per share (BVPS) Market value (price) per share (MVPS) Net income Less: Preferred stock dividends Net income available to common stockholders. Cash flows from operating activities Net income Additions (sources of cash): Depreciation and amortization VALIUM'S MEDICAL SUPPLY CORPORATION Balance Sheet as of December 31, 2024 and 2023 (in millions of dollars) Increase in accrued wages and taxes Increase in accounts payable Subtractions (uses of cash): Increase in inventory 2024 VALIUM'S MEDICAL SUPPLY CORPORATION Income Statement for Years Ending December 31, 2024 and 2023 (in millions of dollars) Earnings before interest, taxes, depreciation, and amortization (EBITDA) Less: Accumulated depreciation Earnings before interest and taxes (EBIT) Less: Interest Earnings before taxes (EBT) Less: Taxes Increase in accounts receivable Net cash flow from operating activities Cash flows from investing activities Subtractions: Increase in fixed assets Increase in other long-term assets Net cash flow from investing activities Cash flows from financing activities Additions: Subtractions: $73 194 314 $ 581 $ 1,076 148 $928 136 Increase in common and preferred stock Increase in long-term debt Increase in notes payable Statement of Cash Flows for Year Ending December 31, 2024 (in millions of dollars) Common stock dividends 2023 $ 884 114 $ 770 136 $906 $1,064 $ 1,645 $ 1,452 Total liabilities and equity $ 72 182 292 $546 Current liabilities: Accrued wages and taxes. Accounts payable Notes payable Total Long-term debt Stockholders' equity: Preferred stock (6 thousand shares) $ Liabilities and Equity Common stock and paid-in surplus (100 thousand shares) Retained earnings Total Prepare a statement of cash flows for Valium's Medical Supply Corporation. Note: Enter your answers in millions of dollars. Amounts to be deducted should be indicated with a minus sign. 295 34 10 12 2024 $894 390 $504 48 $456 34 $422 49 $ 373 78 $ 295 $6 $289 132 $ 157 $2.89 $ 1.32 $ 7.29 $ 8.32 2023 $ 804 353 $ 451 42 $ 409 32 $ 377 43 $ 334 70 $ 264 $6 $ 258 132 $126 $ 2.58 $ 1.32 $ 5.72 $ 6.20 2024 $ 52 154 132 $ 338 $ 572 $6 120 609 $ 735 $1,645 2023 $ 42 142 132 $ 316 $ 558 $6 120 452 $ 578 $ 1,452

FINANCIAL ACCOUNTING
10th Edition
ISBN:9781259964947
Author:Libby
Publisher:Libby
Chapter1: Financial Statements And Business Decisions
Section: Chapter Questions
Problem 1Q
icon
Related questions
Question
Current assets:
Cash and marketable securities
Accounts receivable.
Inventory.
Total
Assets
Fixed assets:
Gross plant and equipment
Less: Accumulated depreciation
Net plant and equipment
Other long-term assets
Total
Total assets
Net sales
Less: Cost of goods sold
Gross profits
Less: Other operating expenses.
Less: Common stock dividends
Addition to retained earnings.
Per (common) share data:
Earnings per share (EPS)
Dividends per share (DPS)
Net income
Less: Preferred stock dividends
Net income available to common stockholders
Book value per share (BVPS)
Market value (price) per share (MVPS)
Cash flows from operating activities
Net income
Additions (sources of cash):
Depreciation and amortization
Increase in accrued wages and taxes
Increase in accounts payable
Subtractions (uses of cash):
Increase in inventory
Increase in accounts receivable
Net cash flow from operating activities
Cash flows from investing activities
Subtractions:
VALIUM'S MEDICAL SUPPLY CORPORATION
Balance Sheet as of December 31, 2024 and 2023
(in millions of dollars)
2024
Increase in fixed assets
Increase in other long-term assets
Net cash flow from investing activities
Cash flows from financing activities
Additions:
Subtractions:
$ 73
194
314
$581
$ 1,076
148
$928
136
VALIUM'S MEDICAL SUPPLY CORPORATION
Income Statement for Years Ending December 31, 2024 and 2023
(in millions of dollars)
Earnings before interest, taxes, depreciation, and amortization (EBITDA)
Less: Accumulated depreciation
Earnings before interest and taxes (EBIT)
Less: Interest
Earnings before taxes (EBT)
Less: Taxes
Increase in common and preferred stock
Increase in long-term debt
Increase in notes payable
Common stock dividends
2023
Statement of Cash Flows for Year Ending December 31, 2024
(in millions of dollars)
$72
182
292
$ 546
$ 884
114
$ 770
136
$906
$ 1,064
$ 1,645 $1,452 Total liabilities and equity
Current liabilities:
Accrued wages and taxes
Accounts payable
Notes payable
Total
Long-term debt
Stockholders' equity:
Preferred stock (6 thousand shares)
$
Liabilities and Equity
Common stock and paid-in surplus (100 thousand shares)
Retained earnings
Total
295
34
10
12
2024
$894
390
$504
48
$ 456
Prepare a statement of cash flows for Valium's Medical Supply Corporation.
Note: Enter your answers in millions of dollars. Amounts to be deducted should be indicated with a minus sign.
34
$ 422
49
$ 373
78
$ 295
$6
$289
132
$157
$ 2.89
$ 1.32
$7.29
$ 8.32
2023
$ 804
353
$ 451
42
$ 409
32
$ 377
43
$ 334
70
$ 264
$6
$ 258
132
$126
$ 2.58
$ 1.32
$ 5.72
$ 6.20
2024
$ 52
154
132
$ 338
$ 572
$6
120
609
$735
$ 1,645
2023
$ 42
142
132
$ 316
$ 558
$6
120
452
$ 578
$ 1,452
Transcribed Image Text:Current assets: Cash and marketable securities Accounts receivable. Inventory. Total Assets Fixed assets: Gross plant and equipment Less: Accumulated depreciation Net plant and equipment Other long-term assets Total Total assets Net sales Less: Cost of goods sold Gross profits Less: Other operating expenses. Less: Common stock dividends Addition to retained earnings. Per (common) share data: Earnings per share (EPS) Dividends per share (DPS) Net income Less: Preferred stock dividends Net income available to common stockholders Book value per share (BVPS) Market value (price) per share (MVPS) Cash flows from operating activities Net income Additions (sources of cash): Depreciation and amortization Increase in accrued wages and taxes Increase in accounts payable Subtractions (uses of cash): Increase in inventory Increase in accounts receivable Net cash flow from operating activities Cash flows from investing activities Subtractions: VALIUM'S MEDICAL SUPPLY CORPORATION Balance Sheet as of December 31, 2024 and 2023 (in millions of dollars) 2024 Increase in fixed assets Increase in other long-term assets Net cash flow from investing activities Cash flows from financing activities Additions: Subtractions: $ 73 194 314 $581 $ 1,076 148 $928 136 VALIUM'S MEDICAL SUPPLY CORPORATION Income Statement for Years Ending December 31, 2024 and 2023 (in millions of dollars) Earnings before interest, taxes, depreciation, and amortization (EBITDA) Less: Accumulated depreciation Earnings before interest and taxes (EBIT) Less: Interest Earnings before taxes (EBT) Less: Taxes Increase in common and preferred stock Increase in long-term debt Increase in notes payable Common stock dividends 2023 Statement of Cash Flows for Year Ending December 31, 2024 (in millions of dollars) $72 182 292 $ 546 $ 884 114 $ 770 136 $906 $ 1,064 $ 1,645 $1,452 Total liabilities and equity Current liabilities: Accrued wages and taxes Accounts payable Notes payable Total Long-term debt Stockholders' equity: Preferred stock (6 thousand shares) $ Liabilities and Equity Common stock and paid-in surplus (100 thousand shares) Retained earnings Total 295 34 10 12 2024 $894 390 $504 48 $ 456 Prepare a statement of cash flows for Valium's Medical Supply Corporation. Note: Enter your answers in millions of dollars. Amounts to be deducted should be indicated with a minus sign. 34 $ 422 49 $ 373 78 $ 295 $6 $289 132 $157 $ 2.89 $ 1.32 $7.29 $ 8.32 2023 $ 804 353 $ 451 42 $ 409 32 $ 377 43 $ 334 70 $ 264 $6 $ 258 132 $126 $ 2.58 $ 1.32 $ 5.72 $ 6.20 2024 $ 52 154 132 $ 338 $ 572 $6 120 609 $735 $ 1,645 2023 $ 42 142 132 $ 316 $ 558 $6 120 452 $ 578 $ 1,452
Expert Solution
trending now

Trending now

This is a popular solution!

steps

Step by step

Solved in 3 steps

Blurred answer
Similar questions
  • SEE MORE QUESTIONS
Recommended textbooks for you
FINANCIAL ACCOUNTING
FINANCIAL ACCOUNTING
Accounting
ISBN:
9781259964947
Author:
Libby
Publisher:
MCG
Accounting
Accounting
Accounting
ISBN:
9781337272094
Author:
WARREN, Carl S., Reeve, James M., Duchac, Jonathan E.
Publisher:
Cengage Learning,
Accounting Information Systems
Accounting Information Systems
Accounting
ISBN:
9781337619202
Author:
Hall, James A.
Publisher:
Cengage Learning,
Horngren's Cost Accounting: A Managerial Emphasis…
Horngren's Cost Accounting: A Managerial Emphasis…
Accounting
ISBN:
9780134475585
Author:
Srikant M. Datar, Madhav V. Rajan
Publisher:
PEARSON
Intermediate Accounting
Intermediate Accounting
Accounting
ISBN:
9781259722660
Author:
J. David Spiceland, Mark W. Nelson, Wayne M Thomas
Publisher:
McGraw-Hill Education
Financial and Managerial Accounting
Financial and Managerial Accounting
Accounting
ISBN:
9781259726705
Author:
John J Wild, Ken W. Shaw, Barbara Chiappetta Fundamental Accounting Principles
Publisher:
McGraw-Hill Education